Close
4

Seqens Seqens

X

Company profile for Polyphor

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
We are a clinical stage, Swiss biopharmaceutical company leading the research and development of a new mechanism of action in solid tumors, CXCR4 inhibition, for combination treatment in oncology. Balixafortide, an innovative molecule based on our inhouse macrocycle chemistry, is developed for treatment of metastatic breast cancer. Balixafortide is a potent and highly selective blocker of CXCR4, a G-protein coupled receptor (G...
We are a clinical stage, Swiss biopharmaceutical company leading the research and development of a new mechanism of action in solid tumors, CXCR4 inhibition, for combination treatment in oncology. Balixafortide, an innovative molecule based on our inhouse macrocycle chemistry, is developed for treatment of metastatic breast cancer. Balixafortide is a potent and highly selective blocker of CXCR4, a G-protein coupled receptor (GPCR) that regulates the trafficking and homing of both cancer cells and cells of the patient’s immune system.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
Polyphor
Switzerland Flag
Country
Country
Switzerland
Address
Address
Hegenheimermattweg 125 CH-4123 Allschwil
Telephone
Telephone
+41 61 567 16 00
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY